[Cholecystokinin antagonists: anxiolytic drugs of the future].
Bourin
M
M
Pharmacologie et GIS Médicament, Faculté de Médecine, Nantes, France.
Bradwejn
J
J
D001008:Anxiety Disorders / Q000188:drug therapy*; D001570:Benzodiazepinones / Q000494:pharmacology / Q000627:therapeutic use; D002766:Cholecystokinin / Q000037:antagonists & inhibitors* / Q000494:pharmacology / Q000627:therapeutic use; D020109:Devazepide; D006801:Humans; D016584:Panic Disorder / Q000139:chemically induced / Q000188:drug therapy; D010418:Pentagastrin / Q000009:adverse effects; D011949:Receptors, Cholecystokinin / Q000187:drug effects / Q000502:physiology
D001570:Benzodiazepinones; D011949:Receptors, Cholecystokinin; D002766:Cholecystokinin; D010418:Pentagastrin; D020109:Devazepide
Les antagonistes de la cholécystokinine: anxiolytiques de demain?